Summary Slide.png (54.96 kB)

Economic Evaluation of Cisplatin Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine for the Treatment of First-Line Advanced Metastatic Triple-Negative Breast Cancer in China: Using Markov Model and Partitioned Survival Model

Download (54.96 kB)
posted on 03.07.2020 by Mingjun Rui, Fenghao Shi, Ye Shang, Rui Meng, Hongchao Li

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.